TrianglePUBLICATIONS · 29664714
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2018 Jun 1
- First author
- Kornblum N
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Kornblum N
- type
- Author
- name
- Zhao F
- type
- Author
- name
- Manola J
- type
- Author
- name
- Klein P
- type
- Author
- name
- Ramaswamy B
- type
- Author
- name
- Brufsky A
- type
- Author
- name
- Stella PJ
- type
- Author
- name
- Burnette B
- type
- Author
- name
- Telli M
- type
- Author
- name
- Makower DF
- type
- Author
- name
- Cheema P
- type
- Author
- name
- Truica CI
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Kornblum N
- type
- Author
- name
- Zhao F
- type
- Author
- name
- Manola J
- type
- Author
- name
- Klein P
- type
- Author
- name
- Ramaswamy B
- type
- Author
- name
- Brufsky A
- type
- Author
- name
- Stella PJ
- type
- Author
- name
- Burnette B
- type
- Author
- name
- Telli M
- type
- Author
- name
- Makower DF
- type
- Author
- name
- Cheema P
- type
- Author
- name
- Truica CI
- type
- Author
- bibliography ids
- nci-bib-13228395c49b6c8e2e7bf47d
- book metadata
- content sha256
- 9c9fa0df6c8bb98bc3c8208efc45b90f44a6df7deadc6bf3b9ff78471534b620
- document type
- citation
- dois
- 10.1200/JCO.2017.76.9331
- electronic publication date
- display
- 2018 Apr 17
- precision
- day
- year
- 2018
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:29664714
- immutable id
- pubmed:29664714@9c9fa0df6c8bb98bc3c8208efc45b90f44a6df7deadc6bf3b9ff78471534b620
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 16
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1556-1563
- volume
- 36
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 29664714
- provenance
- batch id
- c4c0356d060413f719c2
- provider
- NCBI PubMed ESummary
- record sha256
- 128cf9f80cfb8963ec6c4d77f6694b0e69bcd3b58fbc97793c29269a7bbe5a3c
- response sha256
- adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
- retrieved at
- 2026-09-09T23:47:33.674758+00:00
- publication date
- display
- 2018 Jun 1
- precision
- day
- year
- 2018
- publication types
- Clinical Trial, Phase II
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.
Preserved source evidence · Not medical advice